PT1899334E - Compostos de naftiridina - Google Patents
Compostos de naftiridina Download PDFInfo
- Publication number
- PT1899334E PT1899334E PT06773519T PT06773519T PT1899334E PT 1899334 E PT1899334 E PT 1899334E PT 06773519 T PT06773519 T PT 06773519T PT 06773519 T PT06773519 T PT 06773519T PT 1899334 E PT1899334 E PT 1899334E
- Authority
- PT
- Portugal
- Prior art keywords
- sub
- naphthyridine compounds
- histamine
- receptor
- serotonin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69200305P | 2005-06-17 | 2005-06-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1899334E true PT1899334E (pt) | 2008-11-06 |
Family
ID=37263777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT06773519T PT1899334E (pt) | 2005-06-17 | 2006-06-16 | Compostos de naftiridina |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7417054B2 (pt) |
| EP (1) | EP1899334B1 (pt) |
| JP (1) | JP2008543880A (pt) |
| CN (1) | CN101243083A (pt) |
| AT (1) | ATE409188T1 (pt) |
| AU (1) | AU2006261162A1 (pt) |
| CA (1) | CA2612409A1 (pt) |
| DE (1) | DE602006002894D1 (pt) |
| DK (1) | DK1899334T3 (pt) |
| ES (1) | ES2314933T3 (pt) |
| PL (1) | PL1899334T3 (pt) |
| PT (1) | PT1899334E (pt) |
| SI (1) | SI1899334T1 (pt) |
| WO (1) | WO2006138714A2 (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030078347A1 (en) * | 2001-08-28 | 2003-04-24 | General Electric Company | Triazine compounds, polymers comprising triazine structural units, and method |
| CN103788089A (zh) * | 2003-09-17 | 2014-05-14 | 詹森药业有限公司 | 作为血清素受体调节剂的稠合杂环化合物 |
| JP2008546711A (ja) * | 2005-06-17 | 2008-12-25 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Ｃｎｓ障害の処置のためのヘキサヒドロ−ピロロ−イソキノリン化合物 |
| US7598255B2 (en) * | 2005-08-04 | 2009-10-06 | Janssen Pharmaceutica Nv | Pyrimidine compounds as serotonin receptor modulators |
| CN101511785A (zh) * | 2006-06-29 | 2009-08-19 | 詹森药业有限公司 | 取代的苄基胺化合物 |
| EP2046747A1 (en) * | 2006-06-29 | 2009-04-15 | Janssen Pharmaceutica N.V. | Substituted aminomethyl benzamide compounds |
| CA2656075A1 (en) * | 2006-06-29 | 2008-01-03 | Janssen Pharmaceutica N.V. | Butyl and butynyl benzyl amine compounds |
| FR2903904A1 (fr) * | 2006-07-21 | 2008-01-25 | Bioprojet Soc Civ Ile | Association de modafinil et d'un antagoniste ou agoniste inverse du recepteur h3 |
| TW200823204A (en) * | 2006-10-17 | 2008-06-01 | Arena Pharm Inc | Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine H3-receptor useful for the treatment of disorders related thereto |
| WO2008064036A1 (en) * | 2006-11-16 | 2008-05-29 | Janssen Pharmaceutica N.V. | Substituted phenyl propyl amines as histamine h3 receptor and serotonin transporter modulators |
| WO2008109336A1 (en) | 2007-03-01 | 2008-09-12 | Janssen Pharmaceutica N.V. | Tetrahydroisoquinoline compounds as modulators of the histamine h3 receptor |
| US7846930B2 (en) | 2007-05-18 | 2010-12-07 | Janssen Pharmaceutica Nv | Diaryl-substituted tetrahydroisoquinolines as histamine H3 receptor and serotonin transporter modulators |
| JP2011518127A (ja) * | 2008-03-31 | 2011-06-23 | エヴォテック・アクチエンゲゼルシャフト | ヒスタミンｈ３受容体アンタゴニストとしてのテトラヒドロナフチリジンおよびそれらのアザ誘導体 |
| JP5364327B2 (ja) * | 2008-09-26 | 2013-12-11 | 富士フイルム株式会社 | ハロピラジンカルボキサミド化合物の製造方法 |
| CN113024456B (zh) * | 2021-02-23 | 2022-05-13 | 江苏先导药业有限公司 | 一种2-氯烟酸的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH538477A (de) | 1970-01-06 | 1973-06-30 | Hoffmann La Roche | Verfahren zur Herstellung von Isochinolin-Derivaten |
| GB1504424A (en) | 1975-08-09 | 1978-03-22 | Beecham Group Ltd | Isoquinoline-derived aminoethers |
| GB1558043A (en) * | 1976-02-03 | 1979-12-19 | Onoda Cement Co Ltd | Metal squeeze out tube and method and apparatus for forming a powder layer on its surface |
| WO1996040142A1 (en) * | 1995-06-07 | 1996-12-19 | Pfizer Inc. | Heterocyclic ring-fused pyrimidine derivatives |
| EP0978512A1 (en) | 1998-07-29 | 2000-02-09 | Societe Civile Bioprojet | Non-imidazole aryloxy (or arylthio) alkylamines as histamine H3-receptor antagonists and their therapeutic applications |
| EP1246805A1 (en) | 1999-11-03 | 2002-10-09 | Albany Molecular Research, Inc. | 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| EP1113007A1 (en) | 1999-12-24 | 2001-07-04 | Pfizer Inc. | Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| EP1595881A1 (en) | 2004-05-12 | 2005-11-16 | Pfizer Limited | Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands |
| CA2592353A1 (en) * | 2004-12-17 | 2006-06-22 | Janssen Pharmaceutica, N.V. | Tetrahydroisoquinoline compounds for treatment of cns disorders |
-
2006
- 2006-06-16 US US11/424,751 patent/US7417054B2/en active Active
- 2006-06-16 PT PT06773519T patent/PT1899334E/pt unknown
- 2006-06-16 AU AU2006261162A patent/AU2006261162A1/en not_active Abandoned
- 2006-06-16 CA CA002612409A patent/CA2612409A1/en not_active Abandoned
- 2006-06-16 DK DK06773519T patent/DK1899334T3/da active
- 2006-06-16 DE DE602006002894T patent/DE602006002894D1/de not_active Expired - Fee Related
- 2006-06-16 CN CNA200680030064XA patent/CN101243083A/zh active Pending
- 2006-06-16 WO PCT/US2006/023788 patent/WO2006138714A2/en active Application Filing
- 2006-06-16 EP EP06773519A patent/EP1899334B1/en not_active Not-in-force
- 2006-06-16 ES ES06773519T patent/ES2314933T3/es active Active
- 2006-06-16 JP JP2008517211A patent/JP2008543880A/ja not_active Withdrawn
- 2006-06-16 PL PL06773519T patent/PL1899334T3/pl unknown
- 2006-06-16 SI SI200630141T patent/SI1899334T1/sl unknown
- 2006-06-16 AT AT06773519T patent/ATE409188T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1899334B1 (en) | 2008-09-24 |
| WO2006138714A2 (en) | 2006-12-28 |
| US7417054B2 (en) | 2008-08-26 |
| AU2006261162A1 (en) | 2006-12-28 |
| US20060287292A1 (en) | 2006-12-21 |
| ATE409188T1 (de) | 2008-10-15 |
| JP2008543880A (ja) | 2008-12-04 |
| CA2612409A1 (en) | 2006-12-28 |
| DK1899334T3 (da) | 2008-11-24 |
| WO2006138714A3 (en) | 2007-03-15 |
| PL1899334T3 (pl) | 2009-04-30 |
| CN101243083A (zh) | 2008-08-13 |
| EP1899334A2 (en) | 2008-03-19 |
| DE602006002894D1 (de) | 2008-11-06 |
| SI1899334T1 (sl) | 2009-04-30 |
| ES2314933T3 (es) | 2009-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1899334T3 (pl) | Związki naftyrydynowe | |
| HK1118550A1 (en) | Fused heterocyclic compounds as serotonin receptor modulators | |
| ATE496892T1 (de) | Tetrahydroisochinolinverbindungen zur behandlung von zns-erkrankungen | |
| WO2008002820A3 (en) | Substituted benzyl amine compounds | |
| IL213679A0 (en) | Pyrimidine compounds as serotonin receptor modulators | |
| ATE407927T1 (de) | 3-phenyl-pyrazol-derivate als modulatoren des zur behandlung damit zusammenhängender störungen nützlichen 5-ht-2a-serotonin-rezeptors | |
| MY145305A (en) | Cyclopropyl amines as modulators of the histamine h3 receptor | |
| SG149063A1 (en) | Use of modified cyclosporins for the treatment of hcv disorders | |
| CL2008001122A1 (es) | Compuestos derivados de imidazo[1,2,3-ij]-1,8-naftiridin-4,9-diona; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de infecciones bacterianas. | |
| UA89734C2 (en) | ANTAGONISTS of muscarinic acetylcholine receptors | |
| CL2009000161A1 (es) | Compuestos derivados de 2,3,4,5-tetrahidro-1h-pirido[4,3-b]indol; composicion farmaceutica que los comprende; uso en el tratamiento de trastornos neurodegenerativos, cognitivos o psicoticos, enfermedad de alzheimer, entre otros; y un kit que contiene a los compuestos. | |
| CL2009000697A1 (es) | Compuestos derivados de 2-heteroaril-6-fenil-imidazol [1,2-a]piridinas sustituidas; moduladores de receptores not; compuestos intermediarios; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de cancer, inflamacion, enfermedades neurodegenerativas, psiquiatricas, epilepsia, entre otras. | |
| DE502004002571D1 (de) | Substituierte 3-pyrrolidin-indol-derivate | |
| TW200716091A (en) | New therapeutic combinations for the treatment or prevention of psychotic disorders | |
| NO20055563L (no) | Midler for behandlingen av lavere abdominale lidelser | |
| ECSP088366A (es) | 1,2-diarilimidazoles para uso como moduladores de cb1 | |
| AU2003290059A1 (en) | Use of cd137 antagonists for the treatment of tumors | |
| DE602004014772D1 (de) | Pyrrol-2,5-dithionderivate als modulatoren des liver-x-rezeptors | |
| WO2006116311A3 (en) | Opioid receptor agonist compounds and their use in treatment of pain | |
| TW200510398A (en) | Novel compounds | |
| CL2008003659A1 (es) | Compuestos derivados de 6-(4-bencilpiperazin-1-il)pirimidin-4-ona, moduladores de la enzima estearoil-coa-desaturasa 1; procedimiento de preparacion; composicin farmaceutica; y uso en el tratamiento y profilaxis de la obesidad. | |
| MXPA05013478A (es) | Combinaciones terapeuticas. | |
| IL162154A0 (en) | Prostagandin composition for the treatment of erectile dysfunction | |
| CY1110846T1 (el) | Διαμορφωτες υποδοχεων της προγεστερονης του τυπου πυριδοοξαζεπινης | |
| UY29756A1 (es) | Derivados de 5-piridazinil-1-azabiciclo(3.2.1) octano, su preparación y su aplicación en terapéutica. |